Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.

Slides:



Advertisements
Similar presentations
by Pascal Gelebart, Mona Anand, Hanan Armanious, Anthea C
Advertisements

PKCK2 determines TRAIL sensitivity.
FL cells are dependent on BCL6 in a NOTCH2-dependent manner.
Pioglitazone inhibits aromatase expression in human preadipocytes.
Rachel Truitt et al. BTS 2018;3:
A and B, CO-1686–resistant NCI-H1975 cell clones, COR1-1 and COR10-1 display a reduced dependence on EGFR signaling for survival. A and B, CO-1686–resistant.
HIPK2 decreases the stability of Notch1-IC through proteasome-dependent degradation. HIPK2 decreases the stability of Notch1-IC through proteasome-dependent.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
SIRT1 is downregulated in human gastric cancer (GC).
Allopurinol up-regulates DR5 expression in PC-3 and DU145 cells.
TNFα is an important survival and growth signal for melanoma.
Curcumin-generated ROS activates Chk1 and Chk2 kinases.
The sesquiterpene lactone PN up-regulates MDM2 and p53 proteins.
The effects of the FASN blocker C75 on cell growth and survival (A, E, and F), on expression/phosphorylation of PI3K and MAPK signaling proteins and on.
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
Immunohistochemical detection of 8-OHdG by use of the 1F7 monoclonal antibody in oligomer-treated PC3 prostate cancer cells. a, control untreated peripheral.
Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml)
B7-H1–induced reverse signals in myeloma cells.
CDCP1 is required for invadopodia formation and ECM degradation by human breast cancer cells. CDCP1 is required for invadopodia formation and ECM degradation.
The role of p53 in H2O2-mediated cell death of hOGG1-deficient H1299 lung carcinoma p53 null cells. The role of p53 in H2O2-mediated cell death of hOGG1-deficient.
Identification of NSC as a FADD-kinase inhibitor.
Activation of CHOP and DR5 by DIM-C-pPhtBu.
BME treatment increases granzyme B expression in NK 3.3 cells.
Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells. Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells.
Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.
Lamellarin D induces cell death through a Fas-independent pathway.
Lamellarin D activates the intrinsic pathway of apoptosis.
Sensor siRNAs can be used in high-order combinations.
Effects of visfatin on the cell proliferation and phosphorylation of ERK, Akt, and GSK-3β proteins in HCC cells. Effects of visfatin on the cell proliferation.
Expression of CRC stem cell markers and L1 in CRC cells.
Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in.
Effect of SFN on the protein expression of Nrf2, HO-1, and NQO1 in JB6-shMock and JB6-shNrf2 cells. Effect of SFN on the protein expression of Nrf2, HO-1,
Biological effects of BRAF silencing: growth curves of A375 (A) and ARO (B) cell lines in the absence or presence of doxycycline. Biological effects of.
Effect of IL24 on phosphorylation of eIF2α and proliferation in cancer cells. Effect of IL24 on phosphorylation of eIF2α and proliferation in cancer cells.
N-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. n-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. HEC-1-A.
Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma cells. Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma.
CDCP1 links Ras and SFK signaling and regulates anoikis resistance, cell migration, and invasion in NSCLC cells. CDCP1 links Ras and SFK signaling and.
Synergistic cytotoxicity of 17AAG and TNF treatment in human lung cancer cell lines. Synergistic cytotoxicity of 17AAG and TNF treatment in human lung.
The effect of different concentrations of WMC-79 and time of exposure on the growth of HCT-116 cells. The effect of different concentrations of WMC-79.
Ki-67 expression in M31- and H3-treated tumors (A) and respective Ki-67 labeling indices in the two groups of tumors (B). Ki-67 expression in M31- and.
PKCζ is tyrosine phosphorylated by EGF and contributes to EGF-induced activation of ERK in Mef cells. PKCζ is tyrosine phosphorylated by EGF and contributes.
Effects of HDAC2 inactivation on the invasive potential of human gastric cancer cells. Effects of HDAC2 inactivation on the invasive potential of human.
Changes in signal transduction pathway induced by gefitinib.
Expression of the cell death markers activated caspase-3 and LC3 I/II in TUBO cells. Expression of the cell death markers activated caspase-3 and LC3 I/II.
A, percentage of mitotic and multinucleated HeLa MR cells at each time point. A, percentage of mitotic and multinucleated HeLa MR cells at each time point.
Osteoactivin expression is required for the invasive phenotype of in vivo selected bone metastatic 4T1 breast cancer cells. Osteoactivin expression is.
KRASG12D- and BRAFV600E-induced survival in PDECs requires IGF1R signaling. KRASG12D- and BRAFV600E-induced survival in PDECs requires IGF1R signaling.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
SAHA blocks IR-induced increase of RAD51 protein in MM cells.
Effect of bevacizumab on the proliferation of A2780 cells.
Induction of PARP cleavage (A) and activation of caspases (B) after treatment with a combination of TRAIL and cisplatin. Induction of PARP cleavage (A)
Establishment of HeLa/rtTAA/TRE-N1-IC cell line.
Posttranslational phosphorylation of p53 by platinum drugs in ovarian tumor cells. Posttranslational phosphorylation of p53 by platinum drugs in ovarian.
PARP1 suppresses the transcription of PD-L1 in cancer cells.
RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.
Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.
Fig. 3 Effects of ASO and eGLP1-ASO conjugates on gene expression and protein levels in vitro in cell lines and primary mouse islet cells. Effects of ASO.
Influence of minocycline on TGF-β1 expression and TGF-β1–induced NF-кB activation in ovarian cancer cells. Influence of minocycline on TGF-β1 expression.
Mechanism by which flavopiridol induces cell cycle arrest and apoptosis in rhabdoid tumor cells. Mechanism by which flavopiridol induces cell cycle arrest.
BME treatment increases cytotoxic activity of NK3
Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.
Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells. Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
T3 or T4 induces MAPK activation in myeloma cells.
A, Pharmacologically inhibiting protein tyrosine kinases significantly reduces the viability of ATRT cell lines as compared with control HEK 293 cells.
Effects of NMT siRNAs on MARCKS and c-Src.
Inhibition of HDACs disrupts DNMT1 association with Hsp90.
TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.
I3C reduces the level of Cdc25A protein in breast cancer cells.
Sp1 complementation assay.
Presentation transcript:

Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. A. Cells were treated with 50 μmol/L H2O2 for 1 h. The activated (cleaved) caspase-3 and caspase-7 were detected by Western blot analysis using specific antibodies for caspase-3 and caspase-7 at the indicated time points after the H2O2 treatment. Data were normalized with α-tubulin expression. B. After control-siRNA– and hOGG1-siRNA–transfected GM00637 cells were treated with or without 60 μmol/L caspase inhibitor and the indicated concentration of H2O2, caspase-3/7 activities were analyzed using Promega Caspase Glo 3/7 kit as described in Materials and Methods. Data were plotted as the relative units of luciferase intensity of three separate experiments. Points, mean; bars, SD. C. Cell viability was determined by trypan blue exclusion under the same experimental condition as in B. The extent of cell death was estimated as the percentage of total cell number that remained unstained. The control-siRNA–transfected cells served as experimental controls in this study. Points, mean from five separate experiments; bars, SD. Cha-Kyung Youn et al. Mol Cancer Res 2007;5:1083-1098 ©2007 by American Association for Cancer Research